<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01867528</url>
  </required_header>
  <id_info>
    <org_study_id>HUCH-95-150513</org_study_id>
    <nct_id>NCT01867528</nct_id>
  </id_info>
  <brief_title>Comparison of Laparoscopic Surgery Versus Open Surgery in the Treatment of Adhesive Small Bowel Obstruction</brief_title>
  <official_title>Laparoscopic Versus Open Adhesiolysis for Small Bowel Obstruction - A Multicenter, Prospective, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <brief_summary>
    <textblock>
      Small bowel obstruction is a common reason for surgical admission. Most common reason for
      small bowel obstruction is adhesions, which account up to 70-80 % of small bowel
      obstructions. Large proportion of adhesive small bowel obstructions may be treated
      nonoperatively, but up to 50-60% may need surgical intervention. Current golden standard for
      surgical intervention is open adhesiolysis. Recently, retrospective studies have provided
      encouraging results of laparoscopic adhesiolysis for small bowel obstructions. However, no
      prospective randomized trials have been carried out and retrospective series carries a high
      risk for patient selection and bias. Although in general laparoscopy has been associated with
      shortened hospital stay, less pain and reduced mortality, laparoscopic adhesiolysis for small
      bowel obstruction has been reported to cause iatrogenic small bowel lesions up to 7% of
      patients. Aim of the study is to compare open adhesiolysis to laparoscopic adhesiolysis. The
      investigators hypothesis is that laparoscopic adhesiolysis is safe, will shorten the hospital
      stay, and reduce mortality compared to open approach.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative hospital stay (days)</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Passage of stools (post-operative days)</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Commence of enteral nutrition (post-operative days)</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications, Clavien-Dindo classification</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with iatrogenic small bowel lesions</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with readmission(s)</measure>
    <time_frame>30 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant with failure to relieve obstruction</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores on the Visual Analog Scale</measure>
    <time_frame>Postoperative days 1- 7 or till discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of epidural catheter analgesia (days)</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total need of opioids in milligrams</measure>
    <time_frame>Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of sick leave (days)</measure>
    <time_frame>Participants will be followed for the duration of sick leave, depending on occupation estimated 1-4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants that develop ventral hernia</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient with recurrent adhesive small bowel obstruction</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment>102</enrollment>
  <condition>Adhesive Small Bowel Obstruction</condition>
  <arm_group>
    <arm_group_label>Laparoscopic adhesiolysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Open adhesiolysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic adhesiolysis</intervention_name>
    <arm_group_label>Laparoscopic adhesiolysis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open adhesiolysis</intervention_name>
    <arm_group_label>Open adhesiolysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with clinical and computed tomography-diagnosed adhesive small bowel
             obstruction AND

          -  Obstruction is not relieved by conservative methods (nasogastric tube, NPO) including
             Gastrografin is not passed to colon within 8 hours (48-hour conservative treatment
             without Gastrografin® is allowed if Gastrografin® is contraindicated (e.g. allergy) or
             not available)

        Exclusion Criteria:

          -  Strong suspicion of strangulation or clinical peritonitis thus indicating an urgent
             operative intervention

          -  Earlier confirmed or strongly suspected peritoneal carcinosis

          -  Earlier confirmed wide diffuse adhesions of abdominal cavity

          -  Earlier open surgery for endometriosis

          -  Earlier generalized diffuse peritonitis (not including local peritonitis such as
             appendicitis)

          -  Active abdominal malignancy or remission less than 10 years

          -  Earlier abdominal region radiotherapy

          -  Earlier obesity surgery

          -  3 or more earlier open abdominal operations (not including caesarean section(s))

          -  Suspicion of other cause for obstruction than adhesions in CT-scan

          -  Earlier abdominal surgical operation within 30 days

          -  Earlier surgical operation for aorta or iliac vessels performed through laparotomy

          -  Crohn's disease

          -  Anesthesiological contraindication for laparoscopy

          -  Missing informed consent

          -  Age less than 18 years or over 95 years

          -  Pregnancy

          -  Patient living in institutional care (such as health centre ward), not including
             retirement homes

          -  Over 1 week of hospital stay directly prior surgical consultation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ville Sallinen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Panu Mentula, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ari Leppäniemi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ville Sallinen, MD, PhD</last_name>
    <phone>+35894711</phone>
    <email>ville.sallinen@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ville Sallinen</last_name>
      <email>ville.sallinen@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Panu Mentula</last_name>
      <email>panu.mentula@hus.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Ville Sallinen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ari Leppäniemi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Panu Mentula</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Päijät-Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berndt Enholm</last_name>
      <email>berndt.c.enholm@phsotey.fi</email>
    </contact>
    <investigator>
      <last_name>Berndt Enholm</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vesa Koivukangas</last_name>
      <email>vesa.koivukangas@ppshp.fi</email>
    </contact>
    <investigator>
      <last_name>Vesa Koivukangas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eija Haukijärvi</last_name>
      <email>eija.haukijarvi@pshp.fi</email>
    </contact>
    <investigator>
      <last_name>Eija Haukijärvi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paulina Salminen</last_name>
      <email>paulina.salminen@tyks.fi</email>
    </contact>
    <investigator>
      <last_name>Paulina Salminen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vaasa Central Hospital</name>
      <address>
        <city>Vaasa</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Risto Juusela</last_name>
      <email>risto.juusela@vshp.fi</email>
    </contact>
    <investigator>
      <last_name>Risto Juusela</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peijas Hospital</name>
      <address>
        <city>Vantaa</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Wikström</last_name>
      <email>heidi.wikstrom@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Heidi Wikström</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Papa Giovanni XXIII Hospital</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Ansaloni, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bologna Maggiore Hospital</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salomone Di Saverio</last_name>
      <email>salo75@inwind.it</email>
    </contact>
    <investigator>
      <last_name>Salomone Di Saverio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parma University Hospital</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fausto Catena, MD, PhD, FRCS</last_name>
      <email>faustocatena@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2013</study_first_submitted>
  <study_first_submitted_qc>May 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2013</study_first_posted>
  <last_update_submitted>December 4, 2016</last_update_submitted>
  <last_update_submitted_qc>December 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Ville Sallinen</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

